Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2006
03/09/2006US20060052366 Pyridine derivatives as fungicidal compounds
03/09/2006US20060052365 Protease inhibitors
03/09/2006US20060052360 Compounds, compositions and methods
03/09/2006US20060052358 Modulators of ATP-binding cassette transporters
03/09/2006US20060052349 Pyrrolo-naphthyl acids and methods for using them
03/09/2006US20060052348 such as ({6-[2-(2-naphthylmethyl)-1,3-oxazol-5-yl]-2-naphthyl}oxy)acetic acid, used to modulate plasminogen activator inhibitor (PAI-1) gene expression and to treat PAI-1 related disorders; cardiovascular and respiratory disorders; fibrosis, polycystic ovary syndrome, Alzheimer's disease, or cancer
03/09/2006US20060052308 Transglutaminase inhibitors and methods of use thereof
03/09/2006CA2578604A1 Piperidine derivative or pharmaceutically acceptable salt thereof
03/09/2006CA2577495A1 Isoxazoline derivatives and their use as herbicides
03/09/2006CA2577398A1 Urea derivatives as calcium channel blockers
03/09/2006CA2577301A1 Substituted biaryl piperazinyl-pyridine analogues
03/09/2006CA2577275A1 Quinazolinone derivatives and their use as b-raf inhibitors
03/09/2006CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors
03/09/2006CA2571989A1 Modulators of nuclear receptors
03/08/2006EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
03/08/2006EP1632479A2 Piperazine derivatives useful as ccr5 antagonists
03/08/2006EP1632477A1 Benzamide derivative or salt thereof
03/08/2006EP1632470A2 Calcium receptor active molecules
03/08/2006EP1631567A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors
03/08/2006EP1631564A1 Method for preparing fused oxazinones
03/08/2006EP1631561A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
03/08/2006EP1631552A2 Method for synthesising heterocyclic compounds from thiourea derivates
03/08/2006EP1631551A2 Isoquinoline derivatives and their use as gfat inhibitors
03/08/2006EP1631548A2 Inhibitors of akt activity
03/08/2006EP1631546A1 Sustituted indoline and indole derivatives
03/08/2006EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
03/08/2006EP1631296A1 2,3,4,5-tetrahydrobenzo[f][1,4]oxazepine-5-carboxylic acid amide derivatives as gamma-secretase inhibitors for the treatment of alzheimer's disease
03/08/2006EP1631292A1 4-anilino-quinazoline derivatives as antiproliferative agents
03/08/2006EP1631286A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/08/2006EP1631285A1 Therapeutic agents useful for treating pain
03/08/2006EP1631143A1 Hydrazone derivatives for combatting harmful insects and arachnids
03/08/2006EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
03/08/2006EP1406628B1 Tetrahydroquinoline derivatives
03/08/2006EP1349853B1 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
03/08/2006EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
03/08/2006EP1261591B1 7-nitro-2,1,3-benzoxadiazole derivatives and 7-nitro-2,1,3-benzthiadiazole derivatives and dyes, which contain these compounds and which are used for dying keratin fibers
03/08/2006EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes
03/08/2006EP1176959B1 Novel prolines as antimicrobial agents
03/08/2006EP0948327B1 Antidiabetic agents
03/08/2006CN1745077A 促旋酶抑制剂及其用途 Gyrase inhibitors and their use
03/08/2006CN1745071A Novel ethylenediamine derivatives
03/08/2006CN1745063A Compound inhibiting dipeptidyl peptidase iv
03/08/2006CN1744895A N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
03/08/2006CN1244579C Synthesis of 2-oxazolidone derivate by one still process
03/08/2006CN1244576C Chemical compounds
03/08/2006CN1244573C Benzofuran category compound, its preparing method and usage
03/08/2006CN1244567C Process for selectively protecting baccatin derivative and its application in synthesizing tartrialkane
03/07/2006US7009056 Glaucoma; multiple sclerosis
03/07/2006US7009048 Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
03/07/2006US7008958 Such as 2-bromo-6-methoxy-5-(5-oxazolyl)-1H-indole-3-carboxaldehyde for treating disorders associated with inosine monophosphate dehydrogenase (IMPDH); immunosuppressants, anti-cancer agents
03/07/2006US7008953 3-((mono- or di-fluoro-benzimidazol-2-yl))-5-(4-methyl-5-(ethylaminomethyl)pyrid-3-yl)indazole; inhibitors of cyclin dependent kinases(CDK) for use treating cancer and other proliferative disorders such as retinopathy, rheumatoid arthritis
03/07/2006US7008945 Amide derivatives
03/07/2006US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/07/2006US7008942 Cytotoxic agents comprising taxanes and their therapeutic use
03/07/2006US7008753 Optical recording medium
03/07/2006US7008636 such as 5'-Octadecyloxy-[1,1';3',1'']terphenyl-2'-yloxy acetic acid for inhibiting Protien-Tyrosine Phosphatases(PTPases) from rat liver microsomes in vitro; for treatment of associated obesity, glucose intolerance, diabetes mellitus, hypertension
03/02/2006WO2006023865A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
03/02/2006WO2006023783A1 Novel anthranilamides useful for controlling invertebrate pests
03/02/2006WO2006023778A2 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
03/02/2006WO2006023462A1 Histamine h3 receptor agents, preparation and therapeutic uses
03/02/2006WO2006022773A1 Gyrase inhibitors and uses thereof
03/02/2006WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity
03/02/2006WO2006022374A1 2-phenylpyridine derivative
03/02/2006WO2006021654A1 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
03/02/2006WO2006021544A1 2,4-di(aminophenyl) pyrimidines as plk inhibitors
03/02/2006WO2006021454A2 Pyrimidine derivatives
03/02/2006WO2005072132A3 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
03/02/2006WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
03/02/2006US20060047127 Sigma receptor inhibitors
03/02/2006US20060047116 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection
03/02/2006US20060047114 Azabicyclic amine histamine-3 receptor antagonists
03/02/2006US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents
03/02/2006US20060046997 6-Alkenyl -, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
03/02/2006US20060046987 Substituted quinazoline derivatives and their use as inhibitors
03/02/2006US20060046984 2-(3-acetamido-3-isobutyl-2-oxopyrrolidin-1-yl)-N-(3-(3,5-difluorophenyl)-1-hydroxy-1-(4-propoxypyrrolidin-2-yl)propan-2-yl)-4-phenylbutanamide; beta-amyloid peptide inhibitors; neurodegenerative diseases; Alzheimer's Disease, cerebral amyloid angiopathy and Down's Syndrome
03/02/2006US20060046966 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
03/02/2006DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases
03/02/2006DE102004041163A1 Neue Verbindungen mit antibakterieller Aktivität New compounds with antibacterial activity
03/02/2006DE102004040736A1 Verfahren zur Herstellung von Diarylcycloalkylderivaten A process for preparing Diarylcycloalkylderivaten
03/02/2006CA2688912A1 Vasopressin v1a antagonists
03/02/2006CA2578342A1 Method for the production of diarylcycloalkyl derivatives
03/02/2006CA2578168A1 2-phenylpyridine derivative
03/02/2006CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
03/02/2006CA2577857A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
03/02/2006CA2577752A1 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
03/02/2006CA2577528A1 Heterocyclic antiviral compounds
03/02/2006CA2577251A1 Pyrimidine derivatives
03/02/2006CA2577061A1 Histamine h3 receptor agents, preparation and therapeutic uses
03/02/2006CA2573446A1 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
03/02/2006CA2573371A1 Pyrimidines as plk inhibitors
03/02/2006CA2565803A1 Benzoureas having anti-diabetic activity
03/01/2006EP1630159A1 5-HT7 receptor antagonists
03/01/2006EP1630158A1 5-HT7 receptor antagonists
03/01/2006EP1628974A2 Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (tace)
03/01/2006EP1628972A1 INDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/01/2006EP1628971A1 TRIAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
03/01/2006EP1628967A1 Immunosuppressant compounds and compositions
03/01/2006EP1628966A2 4-amino-2(5h)-furanones useful as cholecystokinin antagonists
03/01/2006EP1628961A1 Phenyl quinolines and their use as estrogen receptor modulators
03/01/2006EP1628685A2 Antiviral phosphonate analogs